HomenewsBusiness NewsMetsera says no to Novo; accepts Pfizer’s new acquisition offer of $10bn

Metsera says no to Novo; accepts Pfizer’s new acquisition offer of $10bn

  • November 8, 2025
  • Posted by: Administrator
  • Category: Business News
No Comments


Respiratory syncytial virus (RSV) poses life-threatening risk to infants

Under the terms of the cash deal, Pfizer will pay $65.60 a share upfront and a contingent value right worth up to $20.65 a share

The post Metsera says no to Novo; accepts Pfizer’s new acquisition offer of $10bn appeared first on Arabian Business: Latest News on the Middle East, Real Estate, Finance, and More.



Source link



Leave a Reply